MeRT is an individualized form of rTMS therapy that incorporates:
Quantitative EEG (qEEG) brain mapping
EKG data
Targeted magnetic stimulation
Rather than using a single fixed stimulation pattern, MeRT adjusts stimulation frequency and location based on measured brainwave activity. This allows clinicians to tailor treatment settings to each person’s unique brain patterns.
The transcranial magnetic stimulation (TMS) technology used in MeRT® is FDA-approved to treat Major Depressive Disorder and Obsessive-Compulsive Disorder. The MeRT® system is also FDA-cleared as an adjunctive treatment for Post-Traumatic Stress Disorder (PTSD). Its use for other neurological or cognitive concerns is considered off-label in clinical practice.
MeRT is non-surgical, non-invasive, medication-free, and delivered in an outpatient setting. Treatment involves gentle magnetic pulses applied to specific areas of the scalp to modulate cortical activity.
